alanine has been researched along with Restless Legs Syndrome in 2 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Restless Legs Syndrome: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Merck Serono SA (formerly Serono), under license from Newron Pharmaceuticals SpA (following its acquisition of the rights from Pharmacia and Upjohn AB [now Pfizer Inc]), is developing the oral alpha-aminoamide derivative of milacemide, safinamide, a monoamine oxidase-B and glutamate release inhibitor, for the potential treatment of Parkinson's disease, epilepsy and restless legs syndrome." | 8.84 | Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. ( Chazot, PL, 2007) |
| "Merck Serono SA (formerly Serono), under license from Newron Pharmaceuticals SpA (following its acquisition of the rights from Pharmacia and Upjohn AB [now Pfizer Inc]), is developing the oral alpha-aminoamide derivative of milacemide, safinamide, a monoamine oxidase-B and glutamate release inhibitor, for the potential treatment of Parkinson's disease, epilepsy and restless legs syndrome." | 4.84 | Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. ( Chazot, PL, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liguori, C | 1 |
| Mercuri, NB | 1 |
| Stefani, A | 1 |
| Pierantozzi, M | 1 |
| Chazot, PL | 1 |
1 review available for alanine and Restless Legs Syndrome
| Article | Year |
|---|---|
Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome.
Topics: Alanine; Animals; Benzylamines; Clinical Trials as Topic; Epilepsy; Humans; Molecular Structure; Mon | 2007 |
1 other study available for alanine and Restless Legs Syndrome
| Article | Year |
|---|---|
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.
Topics: Alanine; Benzylamines; Female; Humans; Male; Middle Aged; Parkinson Disease; Restless Legs Syndrome; | 2018 |